JP Morgan Upgrades Dynavax Technologies To Overweight

Analysts at JP Morgan upgraded

from Neutral to Overweight. The price target for Dynavax Technologies has been raised from $15.00 to $36.00. Dynavax Technologies shares have gained 30.75% over the past 52 weeks, while the S&P 500 index has surged 13.49% in the same period. Dynavax Technologies' shares rose 6.01% to $23.98 in pre-market trading.